ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,083.57
      0.36%
      US Tech 100
      21,166.40
      0.44%
      Dow Jones
      44,747.63
      -0.28%
      Brent Oil
      74.165
      -0.56%
      Bitcoin
      96,382.88
      -0.25%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Nextensa SA (NEXTA) Quote

      Nextensa SA

      Nextensa SA (NEXTA)

      EU
      39.00
      -0.15
      (-0.38%)
      Closed February 06 11:30AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      39.00
      Bid
      38.70
      Ask
      39.15
      Volume
      1,850
      38.50 Day's Range 39.00
      35.70 52 Week Range 50.20
      Market Cap
      390.078M
      Previous Close
      39.15
      Open
      39.00
      Last Trade
      16
      @
      39
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,613
      Shares Outstanding
      10,002,000
      Dividend Yield
      -
      PE Ratio
      15.93
      Earnings Per Share (EPS)
      2.45
      Revenue
      126.4M
      Net Profit
      24.49M

      About Nextensa SA

      Sector
      Real Estate Investment Trust
      Industry
      Real Estate Investment Trust
      Website
      www.nextensa.eu
      Headquarters
      Brussels, Brussels-capital Region, Bel
      Founded
      -
      Nextensa SA is listed in the Real Estate Investment Trust sector of the Euronext with ticker NEXTA. The last closing price for Nextensa was 39.15 €. Over the last year, Nextensa shares have traded in a share price range of 35.70 € to 50.20 €.

      Nextensa currently has 10,002,000 shares outstanding. The market capitalization of Nextensa is 391.58 € million. Nextensa has a price to earnings ratio (PE ratio) of 15.93.

      Ask ADVFN Intelligence (AI)

      NEXTA Latest News

      More News

      Nextensa SA: Informations relatives au nombre total de droits de vote et d'actions

      Nextensa SA: Informations relatives au nombre total de droits de vote et d'actions COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉEBruxelles, 31 janvier 2025, 17h40                           ...

      January 31 2025
      UK Regulatory

      Nextensa NV/SA : Information on the total number of voting rights and shares

      Nextensa NV/SA : Information on the total number of voting rights and shares PRESS RELEASE REGULATED INFORMATIONBrussels, 31 January 2025, 5:40 PM                 Nextensa NV/SA : Information on...

      January 31 2025
      UK Regulatory

      Negotiations with Proximus for move to Tour & Taxis enter final stage

      Negotiations with Proximus for move to Tour & Taxis enter final stage PRESS RELEASE REGULATED INFORMATIONINSIDE INFORMATIONBrussels, 22 January 2025, 12 PM            Negotiations with...

      January 22 2025
      UK Regulatory

      Négociations avec Proximus pour un déménagement vers Tour & Taxis entrent dans leur phase finale

      Négociations avec Proximus pour un déménagement vers Tour & Taxis entrent dans leur phase finale COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉESINFORMATIONS PRIVILÉGIÉESBruxelles, 22 janvier...

      January 22 2025
      UK Regulatory

      Nextensa announces successful sale of Brixton Retail Park in Zaventem, Belgium

      Nextensa announces successful sale of Brixton Retail Park in Zaventem, Belgium PRESS RELEASE NON-REGULATED INFORMATIONBrussels, 16 December 2024, 5:40 PM Nextensa announces successful sale of...

      December 16 2024
      UK Regulatory

      Nextensa annonce le succès de la vente du Brixton Retail Park à Zaventem, Belgique

      Nextensa annonce le succès de la vente du Brixton Retail Park à Zaventem, Belgique COMMUNIQUÉ DE PRESSE INFORMATION NON RÉGLEMENTÉEBruxelles, 16 décembre 2024, 07h30          Nextensa annonce...

      December 16 2024
      UK Regulatory

      Nextensa SA: Informations relatives au nombre total de droits de vote et d'actions

      Nextensa SA: Informations relatives au nombre total de droits de vote et d'actions COMMUNIQUÉ DE PRESSE INFORMATIONS RÉGLEMENTÉEBrussels, 28 novembre 2024, 17h40          Nextensa SA...

      November 28 2024
      UK Regulatory

      Nextensa NV/SA : Information on the total number of voting rights and shares

      Nextensa NV/SA : Information on the total number of voting rights and shares PRESS RELEASE REGULATED INFORMATIONBrussels, 28 November 2024, 5:40 PM          Nextensa NV/SA : Information on the...

      November 28 2024
      UK Regulatory

      Nextensa: RÉSULTATS Q3 2024

      Nextensa: RÉSULTATS Q3 2024 INFORMATION RÉGLEMENTÉE Bruxelles, 14 novembre 2024, 17h40 RÉSULTATS Q3 2024 FAITS MARQUANTS IMMEUBLES DE PLACEMENT Les revenus locatifs sont supérieurs de 750K €...

      November 14 2024
      UK Regulatory

      Nextensa: Q3 RESULTS 2024

      Nextensa: Q3 RESULTS 2024 REGULATED INFORMATION Brussels, 14 November 2024, 5:40 PM Q3 RESULTS 2024 HIGHLIGHTS  INVESTMENT PROPERTIES The rental income is €750K higher than in the third...

      November 14 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.45-1.1406844106539.4540.738.5120439.61392857DE
      4-5-11.3636363636444438.5124040.4975279DE
      12-2.6-6.2541.644.835.7161340.07798192DE
      26-1.85-4.5287637698940.8545.1535.7142241.59973805DE
      52-5.5-12.359550561844.550.235.7129443.18071058DE
      156-33.4-46.132596685172.473.935.7231348.8475649DE
      260-33.4-46.132596685172.479.635.7233750.62833133DE

      NEXTA - Frequently Asked Questions (FAQ)

      What is the current Nextensa share price?
      The current share price of Nextensa is 39.00 €
      How many Nextensa shares are in issue?
      Nextensa has 10,002,000 shares in issue
      What is the market cap of Nextensa?
      The market capitalisation of Nextensa is EUR 391.58M
      What is the 1 year trading range for Nextensa share price?
      Nextensa has traded in the range of 35.70 € to 50.20 € during the past year
      What is the PE ratio of Nextensa?
      The price to earnings ratio of Nextensa is 15.93
      What is the cash to sales ratio of Nextensa?
      The cash to sales ratio of Nextensa is 3.09
      What is the reporting currency for Nextensa?
      Nextensa reports financial results in EUR
      What is the latest annual turnover for Nextensa?
      The latest annual turnover of Nextensa is EUR 126.4M
      What is the latest annual profit for Nextensa?
      The latest annual profit of Nextensa is EUR 24.49M
      What is the registered address of Nextensa?
      The registered address for Nextensa is GARE MARITIME , 11 RUE PICARD B505, BRUSSELS, BRUSSELS-CAPITAL REGION, BE-1000
      What is the Nextensa website address?
      The website address for Nextensa is www.nextensa.eu
      Which industry sector does Nextensa operate in?
      Nextensa operates in the REAL ESTATE INVESTMENT TRUST sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALCYBCybergun
      0.0002 €
      (100.00%)
      		12.48M
      MLWEYWeya
      0.027 €
      (68.75%)
      		2k
      ALENTEntreparticuliersCom
      0.75 €
      (52.13%)
      		90.71k
      GIM32Gimv NV
      0.65 €
      (37.71%)
      		477.35k
      ALSASStradim Espac Fin
      6.90 €
      (33.98%)
      		2k
      CLEXCumulex NV
      0.585 €
      (-55.68%)
      		738
      SOISOITEC
      57.70 €
      (-29.72%)
      		1.92M
      TUVDSBio UV Group DS
      0.0231 €
      (-29.36%)
      		620.29k
      ALALOAcheterLouerFR
      0.0227 €
      (-29.06%)
      		2.7M
      MLOCTOctopus Biosafety
      0.144 €
      (-25.39%)
      		10.36k
      ATOAtos SE
      0.0021 €
      (0.00%)
      		402.51M
      ALVERVergnet
      0.0007 €
      (-22.22%)
      		70.45M
      INGAING Groep NV
      15.92 €
      (-0.29%)
      		22.66M
      BCPBanco Comercial Portugues SA
      0.5066 €
      (2.76%)
      		18.96M
      ALNRGEnergisme SA
      0.0037 €
      (12.12%)
      		17.17M

      Discussion

      View Full Feed
      Stern is Bald Stern is Bald 2 minutes ago
      We all do it no problem....
      FNMA
      Wingsjr Wingsjr 2 minutes ago
      Only if you want a reason to sell all your shares now. UM is 💩x10. JC THIS IS THE EASIEST THING TO DO IN THE HISTORY OF CSHIPS!!!! It only takes a 5 word EO to end this. “Fannie and Freddie are RELEASED!”
      FNMA
      ilovetech ilovetech 2 minutes ago
      dstock - The timing of the combo clinical trial updates using Keytrtuda in combination with ATL-DC aka DCVAX is interesting. Northwest had its checkpoint/dendritic cell combo patent approved right around that time.
      https://x.com/HenryMuney/status/1859735319442264473?t=uqMnuRFIRr9TgQw2Esg7Ww
      NWBO
      Pickens Pickens 3 minutes ago
      Time to Change your name to Not Gr8 Dad

      Great Dad would have loaded up and set his family up!!
      RITE
      I-Glow I-Glow 3 minutes ago
      OWCP is on the Expert Market - they lost their 211. Plus they haven't filed any financial information since 09/30/2019.

      I would be more concerned about being revoked by the SEC - but first they would have to suspend OWCP.

      IG
      OWCP
      lifeonthefarm lifeonthefarm 3 minutes ago
      unreal how these scams just delay.i guess they figure they need another 120 days to dilute further? there's like 17b left at least in authorized
      HMBL
      sortagreen sortagreen 3 minutes ago
      yes
      Zorax Zorax 3 minutes ago
      It's entirely possible, with the amount of thread hopping I do that I crossed up your handle with another post.
      For that I am sorry and apologize.
      Were you disappointed in Biden? What I saw seemed like someone down on dems. If I find it again, if it mattered as a defense, I'll bring
      TMaga TMaga 3 minutes ago
      HCMC has elected not to seek rehearing by the panel of the Federal Circuit that ruled on the appeal or rehearing by the entire Federal Circuit. On December 31, 2024, HCMC dismissed the patent infringement action against Philip Morris USA, Inc. and Philip Morris Products S.A. pending in the district
      HCMC
      ExtremelyBullishZig ExtremelyBullishZig 4 minutes ago
      Not sure why you would thumbs down the truth... apparently those who gave me a thumbs down didn't enjoy close of the day that correlated with my post. I guess you can lead a horse to water...
      AVXL
      skitahoe skitahoe 4 minutes ago
      If the company had followed all the late filing regulations and their explanations accepted, do you think the shares price would be what it is, and that most investors couldn't buy shares?

      Gary 
      CRTG
      Jimmy Joe Jimmy Joe 4 minutes ago
      People should refrain from jumping into the deep end if they don't know how to swim.

      Flailing the arms in panic only increases the speed of sinking.

      😸🤣😸😅😸😆😸😂😹


      https://investo
      DBMM
      lifeonthefarm lifeonthefarm 4 minutes ago
      of minus 250k muln accounts for 170k of it and I can prove....I joined 11th estate for a claim of losses in a 2022 lawsuit....muln agreed to 7.2 million payout...nothing to the 100s of millions MICHERY and AULT/others made of that EV FRAUD hustle
      HMBL
      ron_66271 ron_66271 5 minutes ago
      JPM was Responsible for 57% of the Derivative Market.

      Back in 2008, and BofA was responsible for about 30% of the Derivative Contracts.

      JPM got WMB and BS of which there both very large holders of ABS(RMBS/CMBS…) backed by JPM/BofA Derivative Insurance Contracts, theref
      JPM WMB
      LTListener LTListener 5 minutes ago
      Hopefully things are in motion to get off the EM sooner than later and then they roll into continued updates, clinical progress, license/JV/partner, etc. basically act like most clinical stage pharma…
      RSPI
      MyBuster1966 MyBuster1966 5 minutes ago
      Why are you hollering lol? you are a strange person...wake the f up - wake the f up? maybe take some anger management classes or a benzo or three
      HMBL
      PlaceboJeffect PlaceboJeffect 5 minutes ago
      So my question for the bears who hold still. We all know this is going to zero. Henry may declare bankruptcy with these lawsuits, or disappear or.. something. But it's heading to it's inevitable no bid eventually. It's been a long 4 years of it slowly heading that way. 
      Anyway, my question is
      PHIL
      dennisdave dennisdave 6 minutes ago
      hopeful/expects about the MHRA decision IN March
      NWBO
      IHuser IHuser 6 minutes ago
      imo..Covid bagholders are in the red to the tune of $BILLIONS$ AZN


      Hahahahahahahaaaaaaahaaaaaaaaaaaaa~ how bout you aff with IHuser


      AZN



      IHuser
      AZN BILLIONS
      Wingsjr Wingsjr 6 minutes ago
      First off, why the hell does HUD even need to be involved? THEY HAVE NO VOTE and we sure as heck don’t need them to have one. Too many fingers in the pie spells doom.
      FNMA
      dennisdave dennisdave 7 minutes ago
      yeah well as you know Im not a big fan of management, but Im (when forming my opinion as to the way of the delay) giving them this one (somewhat)
      NWBO
      ExtremelyBullishZig ExtremelyBullishZig 7 minutes ago
      Unfortunately, a failure in biotech has no impact on a another's approval. Only the data can prove useful or not. I wish it were the case because the it would be in the bag...but Rett was in the bag once 
      AVXL
      lifeonthefarm lifeonthefarm 7 minutes ago
      are you doing the same here and other symbols you post on calling them scams? this symbol and igpk amongst many others are slam dunks for your sec contact
      SPZI
      STL Stock STL Stock 7 minutes ago
      Nah i will hold. Thanks for the concern 😘
      HMBL

      Your Recent History

      EU
      NEXTA
      Nextensa
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads